These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6104474)

  • 1. [Effects of eterylate on "in vitro" Platelet function in human plasma (author's transl)].
    Ortega MP; Priego JG; Sunkel C; Armijo M
    Arch Farmacol Toxicol; 1980 Apr; 6(1):31-40. PubMed ID: 6104474
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet aggregation inhibition provoked by eterilate, benorylate and their molecular components, in comparison with acetylsalicylic acid].
    Ortega P; Alonso S; Navarro JL
    Arch Farmacol Toxicol; 1978 Apr; 4(1):150-2. PubMed ID: 29570
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of etersalate on human platelet responsiveness. A study in healthy volunteers.
    Ortega MP; Sunkel C; Armijo M; Priego JG
    Arzneimittelforschung; 1987 Feb; 37(2):214-7. PubMed ID: 2883981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental comparative study of acute toxicity and gastric tolerance of eterylate, benorylate and acetylsalicylic acid (author's transl)].
    Alonso S; Armijo M; Piña M
    Arch Farmacol Toxicol; 1978 Dec; 4(3):349-56. PubMed ID: 34365
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the in vitro anti-aggregating action of various salicylic derivatives].
    Sánchez MS; García Rafanell J; Forn J
    Arch Farmacol Toxicol; 1981 Apr; 7(1):89-92. PubMed ID: 7325722
    [No Abstract]   [Full Text] [Related]  

  • 6. [Activity of eterilate, benorylate and acetylsalicylic acid on blood glucose in normal and experimentally diabetic rats].
    Alonso S; Ortega MP; Armijo M
    Arch Farmacol Toxicol; 1983 Aug; 9(2):183-90. PubMed ID: 6140900
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and pharmacological properties of eterylate, a new derivative of acetylsalicylic acid.
    Sunkel C; Cillero F; Armijo M; Piña M; Alonso S
    Arzneimittelforschung; 1978; 28(10):1692-4. PubMed ID: 39567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatives to aspirin, derived from biological sources.
    Whitehouse MW; Rainsford KD; Ardlie NG; Young IG; Brune K
    Agents Actions Suppl; 1977; (1):43-57. PubMed ID: 343554
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of acetylsalicylic acid on human platelet function in vivo at salicylate steady state.
    Simrock R; Missalla A; Schwidtal P; Lischke V; Breddin HK
    Thromb Haemost; 1984 Apr; 51(2):269-71. PubMed ID: 6740559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Action of some salicylates associated with other non-steroidal anti-inflammatory drugs on the release of prostacyclin from the gastric mucosa of the rat].
    Cifone MG; Alesse E; Ianni G; Continenza MA; Conti P
    Boll Soc Ital Biol Sper; 1982 Dec; 58(24):1666-71. PubMed ID: 6762887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies of imidazole 2-hydroxybenzoate (ITF 182), an antiinflammatory compound with an action on thromboxane A2 production.
    Pagella PG; Bellavite O; Agozzino S; Donà GC; Cremonesi P; De Santis F
    Arzneimittelforschung; 1983; 33(5):716-26. PubMed ID: 6603228
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibiting effect of feprazone on "in vitro" human platelet aggregation.
    Montanari C; Sala P; Bonardi G; Prandoni E
    Pharmacol Res Commun; 1976 Oct; 8(5):503-9. PubMed ID: 1026972
    [No Abstract]   [Full Text] [Related]  

  • 13. Consideration of platelet effects in the selection of an anti-inflammatory agent.
    Small RE; Johnson SM
    Clin Pharm; 1987 Oct; 6(10):756-7. PubMed ID: 3505838
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-inflammatory and analgesic effects of eterilate, benorylate and acetylsalicylic acid].
    Piña M; Armijo M
    Arch Farmacol Toxicol; 1978 Apr; 4(1):183-6. PubMed ID: 29572
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prostaglandins: physiological or "foreign" molecules? Some ticklish questions. Biosynthesis. Nutrition. Pathology (author's transl)].
    Devis R
    J Pharm Belg; 1981; 36(1):43-72. PubMed ID: 7014826
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacology of 4(acetamido)phenyl 2-acetoxybenzoate (Win 11450)].
    Rosner I; Malhie P; Mottot G
    Therapie; 1968; 23(3):525-34. PubMed ID: 5740618
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of salicylic acid and pyridinolcarbamate on the platelet aggregation (author's transl)].
    Altman R; Rouvier J; Taboada S; Mosquera G
    Sangre (Barc); 1974; 19(4):385-98. PubMed ID: 4445961
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
    Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of cardiovascular diseases by inhibitors of platelet aggregation (author's transl)].
    Boeynaems JM
    Rev Med Brux; 1982 Jun; 3(6):415-24. PubMed ID: 7111939
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibition of platelet aggregation and its clinical use (author's transl)].
    Cepelák V
    Cas Lek Cesk; 1974 Jan; 113(2):51-5. PubMed ID: 4154807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.